FanRead at Interphex Week Osaka, Feb. 25-27 Demonstration of "STiV," a generative AI for the pharmaceutical industry, at Interphex Week Osaka

Fun Reed Corporation (headquartered in Toshima-ku, Tokyo; Keiichi Kobayashi, President; hereinafter "Fanreed") will exhibit at the 11th Interphex Week Osaka to be held at Intex Osaka from February 25 to 27, 2025, and will conduct a demonstration of its AI utilization platform for the pharmaceutical industry, "STiV ( We will also introduce examples of use of "STiV" by companies that have introduced the platform.

Outline of Exhibit

11th INTERPHEX WEEK OSAKA [Pharmaceutical] [Cosmetics] Research & Manufacturing Exhibition

To register as a visitor, please visit

https://www.interphex.jp/osaka/ja-jp/register.html?code=1269287405074601-SMK

Dates: Tuesday, February 25 - Thursday, February 27, 2025

Time : 10:00-17:00

Venue : Intex Osaka

Fanreed Booth: Booth No. 9-32 (Manufacturing DX Zone)

11th Interphex Week Osaka Exhibit

STiV" is a generative AI developed in response to the needs of pharmaceutical manufacturing companies within the Taiyo Holdings Group, to which Fanreed belongs. It has evolved while incorporating the needs of the field to improve operational efficiency, and now includes a wide variety of functions.

At our booth, you will be able to experience the following additional functions

(1) One-stop support for generating AI business use (functions to be expanded in December 2024)

In addition to highly accurate RAG x search specialized for the pharmaceutical industry, functions such as summarization, translation, proofreading, and AI consultation from general information have been added. This makes it possible to provide one-stop support for the utilization of generative AI business in the pharmaceutical industry.

(2) Low-cost Japanese and U.S. pharmaceutical affairs information collection agency services (functions to be expanded in January 2025)

The pharmaceutical affairs information collection service has been expanded to include guidance and other information issued by the U.S. Food and Drug Administration (FDA) in addition to the existing information issued by the Ministry of Health, Labor and Welfare (MHLW) in Japan. This enables the use of both Japanese and U.S. regulatory information databases at low cost.

Visitors to the FanRead booth will be able to see actual usage scenarios and details of the functions through a demo experience of "STiV. Please take this opportunity to try out the most advanced generative AI technology for the pharmaceutical industry.

STiV", a platform for the pharmaceutical industry to utilize generative AI

https://www.stiv.jp/

Fun-Read Corporation Company Profile

Established in 2013, Fanreed is a consolidated subsidiary of TAIYO HOLDINGS CORPORATION (listed on TSE Prime), and is engaged in services that propose a new way of IT, such as DX promotion, smart agriculture, and smart factories.

President and Representative Director: Keiichi Kobayashi

Establishment: March 26, 2013

Location: Metropolitan Plaza Bldg. 15F, 1-11-1 Nishi-Ikebukuro, Toshima-ku, Tokyo

Company HP ： https://www.funlead.co.jp/